Glycoprotein IX (Platelet) (GP9) Peptide
GP9
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all CD42a (GP9) products
- CD42a (GP9) (Glycoprotein IX (Platelet) (GP9))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- NSLQSVPPGA FDHLPQLQTL DVTQNPWHCD CSLTYLRLWL EDRTPEALLQ
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of GP9 antibody,
Alternative Names: GP9 control peptide, GP9 antibody Blocking Peptide, Anti-GP9 Blocking Peptide, glycoprotein IX, platelet Blocking Peptide, CD42a Blocking Peptide, GPIX Blocking Peptide, GP9, GP-9, GP 9, GP-9 Blocking Peptide, GP 9 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- CD42a (GP9) (Glycoprotein IX (Platelet) (GP9))
- Background
- This gene encodes a small membrane glycoprotein found on the surface of human platelets. It forms a 1-to-1 noncovalent complex with glycoprotein Ib, a platelet surface membrane glycoprotein complex that functions as a receptor for von Willebrand factor. The complete receptor complex includes noncovalent association of the alpha and beta subunits with the protein encoded by this gene and platelet glycoprotein V. Defects in this gene are a cause of Bernard-Soulier syndrome, also known as giant platelet disease. These patients have unusually large platelets and have a clinical bleeding tendency.
- Molecular Weight
- 19 kDa
-
You are here:
